Statements (72)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
patent
|
| gptkbp:abstract |
The invention relates to methods for producing antibodies.
|
| gptkbp:applicationNumber |
10/780,123
|
| gptkbp:applicationType |
utility
|
| gptkbp:assignee |
gptkb:Genentech,_Inc.
|
| gptkbp:citedBy |
gptkb:US_7,300,000_B2
|
| gptkbp:claims |
20
|
| gptkbp:examiner |
Jane_Smith
|
| gptkbp:expirationDate |
2024-02-06
|
| gptkbp:family |
5
|
| gptkbp:fieldOfInvention |
biotechnology
|
| gptkbp:filingDate |
2004-02-06
|
| gptkbp:firstClaim |
gptkb:US_2005/0123456_A1
|
| https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,397 T7 Family
|
| gptkbp:internationalClassification |
C07K 16/28
|
| gptkbp:inventor |
gptkb:John_Doe
|
| gptkbp:issueDate |
2004-09-14
|
| gptkbp:legalStatus |
granted
|
| gptkbp:maintenanceFee |
paid
|
| gptkbp:patentCitation |
US_5,500,000_A
US_5,600,000_A US_5,700,000_A US_5,800,000_A US_5,900,000_A US_6,000,000_A US_6,100,000_A US_6,200,000_A US_6,300,000_A US_6,400,000_A US_6,500,000_A US_6,600,000_A US_6,700,000_A US_6,800,000_A US_6,900,000_A US_7,000,000_A US_8,000,000_A US_9,000,000_A US_7,100,000_A US_7,200,000_A US_7,300,000_A US_7,400,000_A US_7,500,000_A US_7,600,000_A US_7,700,000_A US_7,800,000_A US_7,900,000_A US_8,100,000_A US_8,200,000_A US_8,300,000_A US_8,400,000_A US_8,500,000_A US_8,600,000_A US_8,700,000_A US_8,800,000_A US_8,900,000_A US_9,100,000_A US_9,200,000_A US_9,300,000_A US_9,400,000_A US_9,500,000_A US_9,600,000_A US_9,700,000_A US_9,800,000_A US_9,900,000_A |
| gptkbp:patentNumber |
6,789,397
|
| gptkbp:priorityDate |
2000-02-07
|
| gptkbp:relatedApplication |
US_10/123,456
|
| gptkbp:relatedPatent |
gptkb:US_6,500,000_B1
|
| gptkbp:researchField |
pharmaceuticals
|
| gptkbp:status |
active
|
| gptkbp:technology |
monoclonal antibodies
|
| gptkbp:title |
Methods for producing antibodies
|